Featured Research

from universities, journals, and other organizations

Universal, Voluntary HIV Testing And Treatment? Research Agenda Outlined

Date:
June 9, 2009
Source:
NIH/National Institute of Allergy and Infectious Diseases
Summary:
Could a global program of universal, voluntary, annual HIV testing and immediate treatment for those who test positive effectively extinguish the HIV pandemic? Is such a program feasible? Top HIV/AIDS research leaders at the National Institute of Allergy and Infectious Diseases have set forth a research agenda to answer these and other provocative questions that may help shape the future of HIV prevention.

Could a global program of universal, voluntary, annual HIV testing and immediate treatment for those who test positive effectively extinguish the HIV pandemic? Is such a program feasible? In the June 10 issue of the Journal of the American Medical Association, top HIV/AIDS research leaders at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, set forth a research agenda to answer these and other provocative questions that may help shape the future of HIV prevention.

The inspiration for the research agenda outlined by NIAID Director Anthony S. Fauci, M.D., and the Director of NIAID's Division of AIDS, Carl Dieffenbach, Ph.D., is a mathematical modeling study published by scientists from the World Health Organization (WHO) in The Lancet in January 2009. The model by Granich et al. predicts that within 10 years of implementation, a program of universal, voluntary, annual HIV testing and immediate treatment for those who test positive could reduce HIV incidence from 20 new cases per 1,000 people per year—the current rate in places like South Africa—to less than 1 case per 1,000 per year. Further, the model predicts that this strategy, colloquially called "test and treat," could end the pandemic within 50 years. Some 33 million people globally are infected with HIV today.

"Given these conclusions, test and treat potentially could represent an important public health strategy for fighting HIV/AIDS," says Dr. Fauci. "However, the WHO model is based on numerous assumptions that need to be tested and also raises concerns about individual rights, cost effectiveness and other critical issues that require broad public debate."

To validate these assumptions and address these concerns, Drs. Dieffenbach and Fauci articulate a series of areas that define the test and treat research agenda for scientists in the field:

  • Feasibility of implementing universal HIV testing
  • Relationship of the stage of HIV infection to efficiency of transmission
  • Efficacy of antiretroviral therapy in preventing HIV transmission
  • Long-term impact of drug resistance
  • Behavioral disinhibition (an increase in activities that put an individual at risk for HIV infection)
  • Benefit to the individual of early antiretroviral therapy
  • Cost effectiveness of test and treat program for society

Test and treat is one component of a three-part strategy that NIAID is examining to control the HIV/AIDS pandemic. NIAID-sponsored research under way on the second component involves testing whether antiretroviral drugs can prevent HIV infection in people at high risk for acquiring the virus, an approach known as pre-exposure prophylaxis, or PrEP. NIAID also is pursuing research to understand how HIV establishes and maintains latent pockets of infection; this information will be used in future studies to try to develop ways to control and eliminate the cells carrying latent virus, potentially curing people of HIV.

"NIAID is committed to investigating whether these and other experimental approaches to controlling HIV/AIDS work, because together, they have the potential to dramatically curtail the pandemic," says Dr. Dieffenbach.

NIAID and its many partners also are conducting research to refine and improve proven HIV prevention strategies such as education and behavior modification of people at risk for contracting or transmitting HIV, practical strategies for reducing HIV transmission among illicit injection drug users, antiretroviral treatment to prevent HIV transmission from mother to child, and medically supervised adult male circumcision. Research on still-experimental approaches to HIV prevention such as topical microbicides and vaccines continues as well.


Story Source:

The above story is based on materials provided by NIH/National Institute of Allergy and Infectious Diseases. Note: Materials may be edited for content and length.


Journal References:

  1. CW Dieffenbach and AS Fauci. Universal voluntary testing and treatment for prevention of HIV transmission. Journal of the American Medical Association, 2009; DOI: 10.1001/jama.301.22.2380
  2. RM Granich et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. The Lancet, 2009; DOI: 10.1016/S0140-6736(08)61697-9

Cite This Page:

NIH/National Institute of Allergy and Infectious Diseases. "Universal, Voluntary HIV Testing And Treatment? Research Agenda Outlined." ScienceDaily. ScienceDaily, 9 June 2009. <www.sciencedaily.com/releases/2009/06/090609215935.htm>.
NIH/National Institute of Allergy and Infectious Diseases. (2009, June 9). Universal, Voluntary HIV Testing And Treatment? Research Agenda Outlined. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2009/06/090609215935.htm
NIH/National Institute of Allergy and Infectious Diseases. "Universal, Voluntary HIV Testing And Treatment? Research Agenda Outlined." ScienceDaily. www.sciencedaily.com/releases/2009/06/090609215935.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins